<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><id>http://publicationslist.org/data/olav.yri/atom.xml</id><title>Olav Yri's Publications List</title>
<link rel="self" type="application/atom+xml" href="http://publicationslist.org/data/olav.yri/atom.xml"/><link rel="alternate" type="text/html" href="http://publicationslist.org/olav.yri"/><author><name>Olav Yri</name><uri>http://publicationslist.org/olav.yri</uri></author><icon>$basepathfavicon.ico</icon><subtitle>Recent additions to Olav Yri's PublicationsList.org page</subtitle><logo>http://publicationslist.org/publications.png</logo><updated>2008-08-07T09:29:14Z</updated>

<entry>
<id>http://publicationslist.org/olav.yri/refid1</id>
<updated>2008-08-07T09:28:44Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/olav.yri#refid1'/>
<title type='html'>Failure to achieve castration levels in patients using leuprolide acetate in locally advanced prostate cancer.</title>
<summary type='html'>OBJECTIVE: In a cross-sectional, retrospective, non-randomised study to investigate the possibility that some patients treated with luteinizing hormone releasing hormone analogues (LHRH analogues) fail to reach castration levels of serum testosterone. METHODS: 40 patients treated with a 3-monthly formulation of leuprolide acetate and continuous use of an oral antiandrogen (&quot;Leu group&quot;) and 25 pati...&lt;br/&gt;&lt;br/&gt;Olav Erich Yri, Trine Bjoro, Sophie D Fossa (2006)  &lt;i&gt;Eur Urol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 49: 1 54-8; discussion 58&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/olav.yri/refid2</id>
<updated>2008-08-07T09:28:44Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/olav.yri#refid2'/>
<title type='html'>Characterization of receptor-interacting protein RIP140 in the regulation of SF-1 responsive target genes.</title>
<summary type='html'>Receptor-interacting protein (RIP) 140 interacts with several nuclear receptors, but its function in regulation of nuclear receptor action has been debated. Here we have examined the role of RIP140 in regulation of Steroidogenic factor-1 (SF-1)-dependent transcription. SF-1 interacts with RIP140 through its activation function-2 (AF-2) domain. Several domains of RIP140 interact directly with SF-1,...&lt;br/&gt;&lt;br/&gt;Gunnar Mellgren, Bente Børud, Tuyen Hoang, Olav Erich Yri, Cathrine Fladeby, Ernst Asbjørn Lien, Johan Lund (2003)  &lt;i&gt;Mol Cell Endocrinol&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 203: 1-2 91-103&lt;br/&gt;</summary>
</entry>
<entry>
<id>http://publicationslist.org/olav.yri/refid3</id>
<updated>2008-08-07T09:28:44Z</updated>
<link rel='alternate' type='text/html' href='http://publicationslist.org/olav.yri#refid3'/>
<title type='html'>Biochemical and functional analysis of nuclear receptors as targets in cAMP-dependent control of bovine CYP17.</title>
<summary type='html'>Several lines of evidence have suggested that the nuclear receptor Steroidogenic Factor-1 (SF-1 or Ad4BP) may be directly involved in the cAMP-dependent regulation of steroid hydroxylase genes in adrenocortical cells. In the bovine CYP17 gene, which encodes the cytochrome P450 17alpha-hydroxylase, an SF-1 site is present within cAMP-responsive sequence 2 (CRS2) and mutations which interfere with S...&lt;br/&gt;&lt;br/&gt;J Lund, A Jacob, R Aesöy, O E Yri, G Mellgren (1998)  &lt;i&gt;Endocr Res&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 24: 3-4 497-504&lt;br/&gt;</summary>
</entry>
</feed>
